The report, presented by the Alliance for Patient Access (AfPA) and titled “Biosimilars: Can They Break Through?” will include discussion on the policy issues surrounding biosimilars in the United States. Topics will include:
- Given pending FDA regulations, what are the obstacles in getting biosimilars to market?
- What are the concerns surrounding the labeling or prescriber information, and why is the issue of naming so hotly contested?
People
Related Insights
29 April 2024
Labor & Employment Law Perspectives
DOL Increases Compensation Threshold for Exempt Employees
Starting July 1, 2024, employers must satisfy a higher salary threshold in order to consider employees as exempt from Fair Labor Standards Act overtime rules.
29 April 2024
Labor & Employment Law Perspectives
PWFA Final Rule is Now Published — It Takes Effect June 18, 2024
On April 15, 2024, the Equal Employment Opportunity Commission published a final rule to implement the Pregnant Workers Fairness Act (PWFA)
29 April 2024
Health Care Law Today
2024 Health Care & Life Sciences Top Trends
Foley & Lardner’s 2024 Health Care & Life Sciences Top Trends publication unpacks fast-moving developments to help your business.